Definitive Contract 75N95024C00004
Award Date
12/16/23
Potential Completion Date
12/15/28
Potential Value
$20M
Federal Agency
National Institute on Drug Abuse
Awardee
The Mclean Hospital Corporation
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Belmont, MA 02478, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $7,232,534.30 base award contract issued by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIDA) to The McLean Hospital Corporation Research Management Division, doing business as McLean Hospital. The contract is for the "Assessment of Potential Substance Abuse Treatment Medications in Nonhuman Primate Models" and will run from December 16, 2018 to December 15, 2023. The contract was not set aside for any particular...
This is a $27,844,029.94 cost-reimbursement contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to The McLean Hospital Corporation, a non-profit psychiatric teaching hospital affiliated with Harvard Medical School. The contract, which runs from September 1, 2019 to August 31, 2020 with options to extend through October 31, 2025, is for the NIH NeuroBioBank Brain and Tissue Repository. This repository collects, stores, and...
This is a federal contract award to The Mclean Hospital Corporation, a non-profit psychiatric teaching hospital affiliated with Harvard Medical School. The contract, awarded by the Drug Enforcement Administration (DEA), is a Blanket Purchase Agreement (BPA) with a ceiling value of $1,062,961.53 over five years. The BPA enables the DEA to access Mclean Hospital's expertise in monitoring and regulating controlled substances, regulated chemicals, and emerging drugs. This contract is not...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Institute of Mental Health (NIMH) to The McLean Hospital Corporation, a not-for-profit hospital and research organization affiliated with Harvard Medical School. The $149,266.70 contract is for "TESTMYBRAIN" DESIGN CONSULTING FOR RESEARCH DOMAIN (RDOC) CRITERIA FIELD TEST BATTERY SERVICES SUPPORT. The contract has a completion date of September 25, 2018. The work is being performed...
This is a $5,833,141.44 cost-reimbursable contract awarded by the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, to Virginia Commonwealth University (VCU) for medication discovery research using rat models of drug relapse. The contract has a period of performance from July 10, 2019 to July 9, 2024, with the initial award covering the first year. This contract was awarded under a competitive solicitation that was open to small businesses only, but no...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Southern Research Institute, a non-profit organization. The $1,593,565.26 contract is under the Pharmacology and Toxicology for Neurotherapeutics Program (PTNP) indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The contract is for the 28-day oral toxicity study in monkeys with a 33-day recovery period. Southern Research Institute has subcontracted a...
The Department of Justice Drug Enforcement Administration (DEA) awarded a $136,383.00 firm fixed price purchase order to The Mclean Hospital Corporation, a non-profit research hospital affiliated with Harvard Medical School, to conduct a study on the drug discrimination and locomotor activity of 15 designer benzodiazepine substances. This study aims to gather pharmacological, medical, and epidemiological data to support the DEA's efforts to place these substances under regulatory control under...
This firm fixed price purchase order was awarded by the National Institutes of Health's National Institute on Drug Abuse to Med Associates, Inc. for $25,745.15. The contract calls for Med Associates to deliver smart control modules and accessories within 45 days to support the NIDA IRP's Behavioral Neuroscience and Neuropsychiatry Section laboratory in Baltimore, Maryland. Per the original solicitation, the modules and accessories will be used for animal behavioral research procedures simulating...
This is a definitive cost-no-fee contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to the Business Group On Health, a non-profit organization, for "ENGAGING LARGE EMPLOYERS REGARDING EVIDENCE-BASED MENTAL HEALTH TREATMENT". The contract has a ceiling value of $1,177,677.00 and an ultimate completion date of September 27, 2010. There is no set-aside designation mentioned. The contract was awarded on September 28, 2007 under NIMH-07-DS-0004 and is part...
This federal contract award, with a ceiling value of $1,927,163.66, was issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The contract was awarded to SRI International, a non-profit research and development organization, and is part of NIDA's Pharmacology and Toxicology for Neurotherapeutics Program (PTNP). The contract, which is a Delivery Order under the PTNP Indefinite Delivery Vehicle (IDV), is for IND-enabling studies....